Previous 10 | Next 10 |
Phio Pharmaceuticals Announces Closing of $14.0 Million Private Placement Priced At-the-Market PR Newswire MARLBOROUGH, Mass. , Jan. 25, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immu...
Phio Pharma ([[PHIO]] -5.5%) announces that it has entered into securities purchase agreements with certain institutional and accredited investors to raise about $14M.The company aims to raise the funds through the issuance of its common stock and warrants at a purchase price of $3.07 per sha...
Phio Pharmaceuticals Announces $14.0 Million Private Placement Priced At-the-Market PR Newswire MARLBOROUGH, Mass. , Jan. 21, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-onc...
Phio Pharmaceuticals to Participate in the H.C. Wainwright BioConnect 2021 Conference PR Newswire MARLBOROUGH, Mass. , Jan. 4, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-on...
Universal Security Instruments (UUU) +293%.Technical Communications (TCCO) +214%.Koss Corporation (KOSS) +99%.Tenax Therapeutics (TENX) +80%.New Concept Energy (GBR) +58%.IRIDEX Corporation (IRIX) +23%.SOS Limited (SOS) +10% after announcing partnership with Zhonglu P&C Insuranc...
Nabriva Therapeutics NBRV -30% after priced $15M public offering.Aytu BioScience (AYTU) -25% on raising 'bought deal' offering to $25M.Immutep (IMMP) -24%.Professional Diversity Network (IPDN) -24%.SELLAS Life Sciences Group SLS -21% after announcing positiv...
Penny Stocks to Watch Today Finding the best penny stocks to buy seems simple, but it takes time to identify a clear trend. We saw this week, how quickly these can breakout. We’ve also seen how quickly they can break down. So deciding what type of trading strategy you’...
Phio Pharmaceuticals to Participate in the 3rd Annual Evercore ISI HealthCONx Conference PR Newswire MARLBOROUGH, Mass., Nov. 19, 2020 MARLBOROUGH, Mass. , Nov. 19, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company d...
Phio Pharmaceuticals (PHIO): Q3 GAAP EPS of -$0.40 misses by $0.02.Cash in hand of ~$16.9M.Shares -2.35% AH.Press Release For further details see: Phio Pharmaceuticals EPS misses by $0.02
Phio Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update PR Newswire MARLBOROUGH, Mass., Nov. 10, 2020 MARLBOROUGH, Mass. , Nov. 10, 2020 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company ...
News, Short Squeeze, Breakout and More Instantly...
Phio Pharmaceuticals Corp. Company Name:
PHIO Stock Symbol:
NASDAQ Market:
Phio Pharmaceuticals Corp. Website:
Marlborough, Massachusetts--(Newsfile Corp. - July 12, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) (the "Company"), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells...
Five sites across the U.S. are now participating in the Phase 1b study Marlborough, Massachusetts--(Newsfile Corp. - July 8, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to ...
Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced i...